Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro

Bioorganic & Medicinal Chemistry
2008.0

Abstract

A series of non-nucleoside ethyl 6-hydroxyquinoline-3-carboxylate derivatives were prepared and evaluated in HepG2.2.15 cells. Most compounds inhibited the expression of viral antigens HBsAg or HBeAg at low concentration. Six compounds, 9f(3), 12b(6), 12f(6), 13b(2), 13b(6), and 13f(6), displayed excellent intracellular inhibitory activity and selectivity towards the replication of HBV DNA. Of these six initial hits, compound 13b(6) was the most active.

Knowledge Graph

Similar Paper

Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro
Bioorganic & Medicinal Chemistry 2008.0
Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols
Bioorganic & Medicinal Chemistry 2009.0
Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents
European Journal of Medicinal Chemistry 2011.0
Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives
Journal of Medicinal Chemistry 2006.0
Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus
Bioorganic & Medicinal Chemistry 2010.0
Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives
Journal of Medicinal Chemistry 2010.0
Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors
European Journal of Medicinal Chemistry 2019.0
2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly
Bioorganic & Medicinal Chemistry Letters 2010.0